#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gestational trophoblastic tumour Microvillous inclusion disease Guillain-Barre syndrome Penile cancer Autoimmune haemolytic anaemia Hypoxic-ischaemic encephalopathy Corneal neovascularisation Autoimmune demyelinating disease Alveolar proteinosis Type IIa hyperlipidaemia Mantle cell lymphoma refractory Leukocyte adhesion deficiency Extra-osseous Ewing's sarcoma recurrent Anaplastic large cell lymphoma T- and null-cell types Muscular dystrophy More trials…

    Learn about Rare Diseases

    Adrenogenital syndrome – Diagnostics Behcet’s syndrome – Basic Information Usher’s syndrome – Life with Disease Pemphigoid Primary immunodeficiency syndrome – Basic Information Synovial sarcoma recurrent – Treatment Haemophilia B with anti factor IX – Treatment Alport’s syndrome – Life with Disease Familial amyotrophic lateral sclerosis – Life with Disease Isodicentric chromosome 15 syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ubamatamab Azd4831 Clindamycin Regn7075 Tyra-300-B01 Bi 1291583 Terlipressin Cenerimod Ofatumumab Azd7798 Mk-4830 Salbutamol Metformin Leuprorelin ALN-4324 Deferoxamine Ficlatuzumab Atropine Sulfate Monohydrate Ads-013 Syn2 More therapies…

    Learn about Your Condition

    Diabetic gastroparesis Anal squamous cell carcinoma Immune thrombocytopenia Cleft lip and palate Hyperadrenocorticism Shprintzen-Goldberg syndrome Implantation complication Glomerulonephritis Prostate cancer recurrent Arthroscopy Kidney transplant rejection Thrombotic microangiopathy Adenocarcinoma Tendon injury Oxygen saturation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Dominant or Mixed-Type Irritable Bowel Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Irritable bowel syndrome
    Investigated Drugs:
    • Coffee Charcoal
    • Dry Extract From Chamomile Flower (4-6:1): Extraction Solvent: Ethanol 60% (M/M)
    • Myrrh
    Germany

  • Study on the Safety and Effectiveness of VX-880 for Patients with Type 1 Diabetes and Severe Low Blood Sugar Awareness

    Recruiting

    4 1 1
    Investigated Drugs:
    • ZIMISLECEL
    France Germany Italy The Netherlands Norway

  • Study on Tabelecleucel for Patients with Epstein-Barr Virus-Associated Diseases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Epstein-Barr virus associated lymphoproliferative disorder
    Investigated Drugs:
    • Tabelecleucel
    Austria Belgium France Italy Spain

  • Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    • Cyclophosphamide
    Austria Belgium Czechia Denmark France Germany +5

  • Study Comparing Lithium and Cariprazine for Treating Bipolar Depression in Patients with Bipolar Type 1 or 2 During a Depressive Episode

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Cariprazine
    Denmark

  • Study of Volrustomig and Drug Combination for Patients with Early-stage Resectable Non-small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer stage IIIA
    Investigated Drugs:
    • Falbikitug
    • Monalizumab
    • Oleclumab
    Belgium France Hungary Ireland Italy Portugal +1
Previous Page
1 … 389 390 391 392 393 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!